Karasu, B. And ÇELEBİ, A. R. C. 2022. The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization. INTERNATIONAL OPHTHALMOLOGY , vol.42, no.9 , 2729-2740.

Karasu, B., & ÇELEBİ, A. R. C., (2022). The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization. INTERNATIONAL OPHTHALMOLOGY , vol.42, no.9, 2729-2740.

Karasu, Bugra, And ALİ RIZA CENK ÇELEBİ. "The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization," INTERNATIONAL OPHTHALMOLOGY , vol.42, no.9, 2729-2740, 2022

Karasu, Bugra And ÇELEBİ, ALİ R. . "The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization." INTERNATIONAL OPHTHALMOLOGY , vol.42, no.9, pp.2729-2740, 2022

Karasu, B. And ÇELEBİ, A. R. C. (2022) . "The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization." INTERNATIONAL OPHTHALMOLOGY , vol.42, no.9, pp.2729-2740.

@article{article, author={Bugra Karasu And author={ALİ RIZA CENK ÇELEBİ}, title={The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization}, journal={INTERNATIONAL OPHTHALMOLOGY}, year=2022, pages={2729-2740} }